NCT00057473 - A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumors | Biotech Hunter

Timeline

Start Date

February 28, 2003

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions

Neoplasms

Interventions

DRUG

carboplatin + irinotecan

Solution, IV, Carbopaltin AUC 4 mg/ml.min every 21 days; irinotecan 12 mg/m2/day x 10 days , Minimum of two cycles of chemotherapy projected to be up to 6.

DRUG

irinotecan

Solution, IV, irinotecan 12 mg/m2/day x 10 days, minimum of two cycles of chemotherapy projected to be up to 6.

Trial Locations (2)

Unknown

Local Institution, Orlando

Local Institution, Houston